This article describes how behavioral science can be applied in cardiometabolic clinical research to augment drug interventions. This combined approach addresses the Health Inequity gap while also increasing patient engagement.
Chief Executive Officer
Chief Technology Officer
Chief Financial Officer
Chief Compliance Officer
Diabetes ExpertÂ
Cardiology Expert
Rare Disease Expert
Oncology Expert
Insert HTML text here.